Authors/Disclosures
|
Jonathan Kleinman, MD
(BlueSky Neurology)
|
Dr. Kleinman has nothing to disclose. |
|
Nancy Fischbein, MD
(Stanford University Medical Center)
|
Dr. Fischbein has received publishing royalties from a publication relating to health care. |
|
Alisa Gean, MD
(University of California)
|
No disclosure on file |
|
Ryan W. Snider
|
No disclosure on file |
|
Michael Mlynash
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Chitra Venkatasubramanian, MD, MBBS, MSc, FNCS
(Stanford Stroke Center, Center for Academic Medicine)
|
Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell . Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKeen and associates. Dr. Venkatasubramanian has stock in Ceribell. The institution of Dr. Venkatasubramanian has received research support from Bard Inc. The institution of Dr. Venkatasubramanian has received research support from Biogen. The institution of Dr. Venkatasubramanian has received research support from NIH. The institution of Dr. Venkatasubramanian has received research support from Alnylam. |
|
Jean-Marc Olivot
|
No disclosure on file |
|
Gregory W. Albers, MD
(Stanford University)
|
No disclosure on file |
|
Christine A. Wijman, MD
(Stanford Neurocritical Care Program, Stanford Stroke Center, SUMC)
|
No disclosure on file |
|
|
No disclosure on file |